Cardiac Diagnostics Catheters Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET OVERVIEW
Cardiac diagnostic catheters are thin, flexible tubes inserted into the heart through a vein or artery to diagnose and treat heart-related conditions. These catheters are used to measure blood pressure and oxygen levels in the heart, take tissue samples, and perform diagnostic imaging tests such as angiography that use contrast dyes and X-rays to visualize blood vessels in the heart. Cardiac diagnostic catheters, to provide a complete evaluation of heart function, are normally employed in conjunction with complementary diagnostic tools like electrocardiographic ECG and echocardiography. They are often used to diagnose heart disease, valve disorders, arrhythmias, and congenital heart defects.
The “Global Cardiac Diagnostics Catheters Market Analysis to 2028” is a specialized and in-depth study of the medical devices industry with a special focus on global market trend analysis. The report aims to provide an overview of the cardiac diagnostics catheters Market with detailed market segmentation by product, indications, end-user, and geography. The report provides key statistics on the market status of the leading cardiac diagnostics catheters market players and offers key trends and opportunities in the market.
MARKET DRIVERS
Factors driving the cardiac diagnostics catheters market growth are the rising prevalence of cardiovascular diseases, technological advancement in catheters, and an increase in demand for minimally invasive treatments. However, the device and procedure costs are high, and lack of skilled professionals. The increase in demand for minimally invasive treatments is boosting the market growth. In terms of patients and doctors, a preference is emerging for the use of less intrusive procedures like catheter diagnostics due to several advantages they provide over conventional diagnostic methods. The reduction in pain, a shorter recovery period, and fewer scars are also associated with these benefits. Therefore, the demand for diagnostic catheters is driven by the growing number of patients who prefer to undergo less extensive procedures. These devices allow doctors to access the inside of the body without too much incision, which has a major impact on Minimally Invasive Procedures. Such tools can collect important diagnostic data such as blood flow and pressure measurements without more invasive procedures. Additionally, advancements in technology, such as robotic-assisted surgery, have made minimally invasive treatments more effective, leading to increased demand. Thus, the Increase in demand for minimally invasive treatments is fueling the cardiac diagnostics catheters market growth.
GLOBAL SEGMENTAL ANALYSIS
The global cardiac diagnostics catheters market is segmented product, indications, and end-user. The global cardiac diagnostics catheters market based on the product bifurcated into diagnostic imaging catheters and non-imaging diagnostic catheters. Diagnostic imaging catheters segment is further sub segmented into angiography catheters, electrophysiology catheters, ultrasound catheters, optical coherence tomography catheters, and others. The non-imaging diagnostic catheters is further sub segmented into pressure & hemodynamic monitoring catheters, temperature monitoring catheters, and others. Based on indication, the market is segmented into coronary artery disease, evaluate the left ventricular function, assessment of pericardial and myocardial diseases, assessment of congenital heart diseases, and evaluation of heart failure. The market is segmented into hospitals, diagnostic centers, and others based on end user.
Based on end user, the hospital segment dominates the global cardiac diagnostics catheters market share. In terms of patients and doctors, a preference is emerging for the use of less intrusive procedures like catheter diagnostics due to several advantages they provide over conventional diagnostic methods. Most of the hospitals provide the cardiac diagnostics using catheters. Further increasing number of hospitals with cardiac care unit is driving the segment growth. Thus, the hospital segment drives the growth of the cardiac diagnostics catheters market.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides cardiac diagnostics catheters market size and forecast estimates from the year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East & Africa (MEA), and South & central America. The cardiac diagnostics catheters market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides an exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South & central America after evaluating political, economic, social and technological factors affecting the cardiac diagnostics catheters market in these regions.
Asia Pacific region is expected to grow with fastest growth rate. The growing awareness of invasive surgery and rising demand for technically advanced imaging equipment contributed to the dominant position on the market. The market growth in emerging countries will be stimulated by initiatives and massive investments in improving healthcare infrastructure in these regions.
Cardiac Diagnostics Catheters Market Report Analysis
CAGR (2023 - 2031)
US$ XX Million
US$ XX Million
Report Coverage
Key Players
Regional Overview
Market Segmentation
By Product
By Indications
By End-User
The report covers key developments in the cardiac diagnostics catheters market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved the way for the expansion of business and the customer base of market players. The market payers from the cardiac diagnostics catheters market are anticipated to have lucrative growth opportunities in the future with the rising demand for cardiac diagnostics catheters in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the cardiac diagnostics catheters market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Abbott Laboratories
- Boston Scientific Corporation
- Ares Medikal
- Medtronic plc
- BrosMed Medical Co. Ltd.
- Cascade Health Care
- Johnson & Johnson
- Koninklijke Philips N.V.
- Merit Medical Systems
- Teleflex Incorporated
Recent Developments
- In August 2022, Medtronic fully completed the acquisition of Affera, Inc. By incorporating its first-ever cardiac mapping and navigation technology that provides a unique, completely integrated diagnostic-focused pulsed field and radiofrequency ablation solution; this purchase has made it possible to increase the company's offer of cardiac ablation technologies.
- In February 2022, the FDA approved an expanded indication for the use of specialized catheters and coronary guidewires during CTO PCI procedures for Teleflex.
- In Sep 2022, The OCTARAY mapping catheter, powered by TRUEre Technology and CARTO3 Version 7, is now available from Biosense Webster Inc., part of J&J MedTechii. OCTARA mapping catheters have been developed to map cardiac arrhythmias, including atrial fibrillation AFib. This catheter has eight strands with improved electrode spacing options to provide a shorter, more efficient mapping time than PENTARAYTM NAV ECO Mapping Catheters, which may shorten the overall ablation period.
- In May 2023, Abbott said it had received FDA approval for its TactiFlex Ablation Catheter, a sensor-enabled catheter expressed by the company as the world's most advanced ablation catheter that uses an innovative tip and contact force technology.
The Insight Partner’s dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Cardiac Diagnostics Catheters Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ XX Million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2023 - 2031) | XX% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Abbott Laboratories
2. Boston Scientific Corporation
3. Ares Medikal
4. Medtronic plc
5. BrosMed Medical Co. Ltd.
6. Cascade Health Care
7. Johnson & Johnson
8. Koninklijke Philips N.V.
9. Merit Medical Systems
10. Teleflex Incorporated
Get Free Sample For